1 | regimens | 11,125 |
2 | schedules | 1,358 |
3 | regimes | 735 |
4 | regiments | 34 |
5 | refreshers | 13 |
6 | dispensations | 12 |
7 | punctoplasty | 7 |
8 | positivities | 6 |
9 | limb-lengths | 4 |
10 | interruption/discontinuation | 3 |
11 | aspirin/corticosteroids | 2 |
12 | changers | 2 |
13 | ta-hpv | 2 |
14 | 303n | 1 |
15 | alone.cmh | 1 |
16 | chemo/immunotherapy | 1 |
17 | cisplatin/docetaxel/irinotecan | 1 |
18 | delay/discontinuation | 1 |
19 | glucosamine/cs | 1 |
20 | group—were | 1 |
21 | microconstituents | 1 |
22 | non-salmonella-infected | 1 |
23 | panabinostat | 1 |
24 | régimes | 1 |
25 | score/average | 1 |
1 | 303n | 1 |
2 | alone.cmh | 1 |
3 | aspirin/corticosteroids | 2 |
4 | changers | 2 |
5 | chemo/immunotherapy | 1 |
6 | cisplatin/docetaxel/irinotecan | 1 |
7 | delay/discontinuation | 1 |
8 | dispensations | 12 |
9 | glucosamine/cs | 1 |
10 | group—were | 1 |
11 | interruption/discontinuation | 3 |
12 | limb-lengths | 4 |
13 | microconstituents | 1 |
14 | non-salmonella-infected | 1 |
15 | panabinostat | 1 |
16 | positivities | 6 |
17 | punctoplasty | 7 |
18 | refreshers | 13 |
19 | regimens | 11,125 |
20 | regiments | 34 |
21 | regimes | 735 |
22 | régimes | 1 |
23 | schedules | 1,358 |
24 | score/average | 1 |
25 | ta-hpv | 2 |
1 | non-salmonella-infected | 1 |
2 | score/average | 1 |
3 | group—were | 1 |
4 | alone.cmh | 1 |
5 | 303n | 1 |
6 | cisplatin/docetaxel/irinotecan | 1 |
7 | interruption/discontinuation | 3 |
8 | delay/discontinuation | 1 |
9 | glucosamine/cs | 1 |
10 | aspirin/corticosteroids | 2 |
11 | positivities | 6 |
12 | schedules | 1,358 |
13 | regimes | 735 |
14 | régimes | 1 |
15 | limb-lengths | 4 |
16 | regimens | 11,125 |
17 | dispensations | 12 |
18 | changers | 2 |
19 | refreshers | 13 |
20 | regiments | 34 |
21 | microconstituents | 1 |
22 | panabinostat | 1 |
23 | ta-hpv | 2 |
24 | chemo/immunotherapy | 1 |
25 | punctoplasty | 7 |